New York, NY -- (SBWIRE) -- 06/21/2019 -- The scope of the report includes liquid biopsy technologies, applications, industry subsegments, biomarker technologies, major funding initiatives, NIPT methods, patents for both liquid biopsy and NIPT, and company profiles. The market sizes for liquid biopsy diagnostics with emphasis on NIPT are given for the years 2017, 2018 (estimated) and 2023 (forecasted).

This report reviews liquid biopsy biomarkers and technologies and provides background on why liquid biopsy is increasingly viewed as a replacement for, or a companion to, tissue biopsy. It then discusses several of the significant large-scale research initiatives that are contributing to liquid biopsy development. Market-driving forces are also discussed.

Get Free Sample Copy of Report @ https://www.marketexpertz.com/sample-enquiry-form/44604

The market for liquid biopsy diagnostics is analyzed by application (cancer, reproductive health, transplant), biomarker type (nucleic acids, cells, extracellular vesicles, proteins), analysis platform (microarray, NGS, PCR, proteomics and others), analysis purpose (screening/early detection, diagnosis, therapy guidance, monitoring) and geography (North America, Europe, Asia-Pacific, Rest of World). Similarly, the market size of non-cancer applications of liquid biopsy, NIPT, is analyzed based on risk-type, analysis purpose, biomarker class, analysis method, NIPT methods, high- and low-risk pregnancies, and geography.

Leading players of Liquid Biopsy including:
- Agilent Technologies
- Illumina
- Natera
- Oxford Nanopore
- QIAGEN
- Thermo Fisher

Major Regions that plays a vital role in Liquid Biopsy market are:
- North America
- Europe
- China
- Japan
- Middle East & Africa
- India
- South America
- Others

Make an Inquiry before buying this report @ https://www.marketexpertz.com/make-enquiry-form/44604

Reasons for Doing This Study
Traditional biopsy methods are often invasive, uncomfortable and carry risks of side effects. Liquid biopsy addresses these issues because it is noninvasive and carries little, if any, risks of side effects. Noninvasive prenatal testing (NIPT) is a liquid biopsy approach that has revolutionized medical genetics. NIPT is a blood test that detects with remarkable accuracy the risk of a fetus developing chromosomal abnormalities like Down syndrome, Edwards syndrome or Patau syndrome, as well as abnormalities with the X and Y sex chromosomes. NIPT involves a simple blood draw, unlike invasive methods such as chorionic villus sampling (CVS) or amniocentesis, each of which also has a small chance of miscarriage. NIPT comes with no risk of miscarriage.

In the age of genomics and personalized medicine, it is critical for clinicians to have diagnostic tools that can be used on a regular basis to screen, monitor, conduct surveillance, guide treatment or otherwise give valuable genomic information about a disease. Liquid biopsy provides this capability and thus is of high interest to the medical community. NIPT is used as a first screen for identifying high-risk pregnancies and will, in the future, be used for low-risk pregnancies as well.

Buy This Report @ https://www.marketexpertz.com/checkout-form/44604

Report Includes:
- 45 data tables and 94 additional tables
- An overview of liquid biopsy and non-invasive prenatal tests (NIPT) market
- Analyses of global market trends with data from 2017, 2018 and projections of compound annual growth rates (CAGRs) through 2023
- Country specific data and analysis for China, Japan, India, South Korea, UK, Germany, France, Italy, Spain and USA
- Comparative study of liquid biopsy with conventional biopsy and coverage of their respective biomarkers
- Snapshot of key liquid biopsy research and development programs
- Information on NIPT available in market such as NIFTY, Verifi prenatal test, Harmony prenatal test, Panorama, MaterniT21 and IONA test
- Description of chromosomal diseases where NIPT plays a vital role in detection and screening i.e. Down's Syndrome, Edwards Syndrome (Trisomy 18), Patau syndrome (Trisomy 13) and Turner syndrome

The research provides answers to the following key questions
- What is the expect growth rate and market size of the Liquid Biopsy market for the forecast period 2018 - 2023.
- What are some of the prominent factors influencing the progress of the Liquid Biopsy industry worldwide?
- What are the winning strategies that differentiate the major market players operating in the industry from the rest?
- What are the past and future market trends influencing the development of the Liquid Biopsy market?
- What threats likely to hinder the development of the Liquid Biopsy market during the estimated period?
- What are the opportunities major vendors are relying heavily on for the forecast period 2018 - 2023?

Browse the report description @ https://www.marketexpertz.com/industry-overview/liquid-biopsy-market

About MarketExpertz
Planning to invest in market intelligence products or offerings on the web? Then marketexpertz has just the thing for you - reports from over 500 prominent publishers and updates on our collection daily to empower companies and individuals catch-up with the vital insights on industries operating across different geography, trends, share, size and growth rate. There's more to what we offer to our customers. With marketexpertz you have the choice to tap into the specialized services without any additional charges.

Contact Us:
John Watson
Head of Business Development
Market Expertz | Web: www.marketexpertz.com
Direct Line: +1-800-819-3052
E-mail: sales@marketexpertz.com
News: www.marketexpertz.com/market-news